Home › Pharmacology › Phenoxymethylpenicillin

Phenoxymethylpenicillin

Phenoxymethylpenicillinum

For medical students2 min readUpdated 2026-10-10

Phenoxymethylpenicillin (Penicillin V) is a natural antibiotic belonging to the beta-lactam group. Unlike most natural penicillins, it is stable in the acidic environment of the stomach, allowing for enteral (oral) administration.

ClassBeta-lactam antibiotics (natural penicillins)

Key FeatureAcid-stable (contains a phenoxymethyl group)

Formulation0.25 g tablets

AdministrationOrally before meals, 6 times daily

VulnerabilityHydrolyzed by bacterial β-lactamases

Classification of Natural Penicillins

To understand the role of phenoxymethylpenicillin in pharmacology, it is necessary to review the general classification of natural penicillins. The primary division criterion within this group is resistance to gastric acid and, consequently, the route of administration.

Acid-labile (parenteral administration). Completely destroyed in the stomach, administered via injection only. These are subdivided into short-acting agents (benzylpenicillin sodium and potassium salts) and long-acting depot preparations (procaine benzylpenicillin, benzathine benzylpenicillin — Bicillin-1, and their combination — Bicillin-5).
Acid-stable (enteral administration). The sole representative of this group in the standard classification is phenoxymethylpenicillin.

Chemical Structure

The key difference between this drug and its parenteral counterparts lies in its chemical structure. Its molecule contains a phenoxymethyl group, replacing the benzyl group characteristic of benzylpenicillin.

This structural modification provides the antibiotic with a crucial property: it resists degradation by hydrochloric acid within the gastric lumen. Because of this acid stability, the drug can be administered orally (per os).

Spectrum of Activity and Limitations

Despite the structural differences that allow the drug to survive in the gastrointestinal tract, its antimicrobial spectrum is completely identical to that of benzylpenicillin.

When prescribing this agent, clinicians must consider the general limitations inherent to all natural penicillins:

Relatively narrow spectrum of antimicrobial activity.
High vulnerability to bacterial enzymes. The drug is readily inactivated by $eta$-lactamases (penicillinases). If an infection is caused by a strain producing these enzymes, therapy will be ineffective.

Formulation and Administration

According to standard prescribing guidelines, the drug is used as follows:

Formulation: 0.25 g tablets.
Route of administration: Orally (per os), strictly before meals.
Dosing regimen: 0.25 g 6 times daily.

The high frequency of administration (6 times daily) requires strict patient compliance to maintain constant therapeutic blood concentrations of the antibiotic.

Mnemonic

PHENOxymethylpenicillin has PHENOmenal acid stability thanks to its PHENOxymethyl group — the only natural penicillin that survives the stomach.

Frequently asked questions

What is the mechanism of action of phenoxymethylpenicillin on bacterial cells?

The mechanism of action involves inhibiting bacterial cell wall synthesis, leading to cell death (bactericidal effect). Phenoxymethylpenicillin blocks the activity of the enzyme transpeptidase.

As a result of this process:

Cross-linking between peptidoglycan chains is disrupted.
Synthesis of a functional cell wall is halted.
Cell wall integrity decreases, ultimately leading to bacterial lysis.

Which specific types of bacteria are included in the spectrum of phenoxymethylpenicillin?

The activity spectrum of phenoxymethylpenicillin is identical to that of benzylpenicillin, covering predominantly Gram-positive flora and a select group of other microorganisms.

Susceptible pathogens:

Gram-positive cocci — streptococci (Streptococcus spp.), pneumococci (S. pneumoniae), and staphylococci (Staphylococcus spp.) that do not produce $\beta$-lactamases.
Gram-positive bacilli — causative agents of diphtheria (Corynebacterium diphtheriae), anthrax (Bacillus anthracis), and listeriosis (Listeria monocytogenes).
Gram-negative cocci — meningococci (Neisseria meningitidis) and gonococci (Neisseria gonorrhoeae).
Anaerobes — clostridia (Clostridium spp.).
Spirochetes — Treponema pallidum, Leptospira spp., and Borrelia spp.
Actinomycetes.

In what conditions is phenoxymethylpenicillin indicated?

Phenoxymethylpenicillin is administered orally and can be used as a drug of choice for targeted therapy during the acute phase of rheumatic fever, aimed at eradicating streptococcal infection.

What side effects are associated with phenoxymethylpenicillin?

The drug exhibits side effects typical of the biosynthetic penicillin group.

Major adverse reactions:

Allergic reactions — urticaria, rash, bronchospasm, angioedema, and anaphylactic shock.
Gastrointestinal disorders — dyspepsia (abdominal pain, nausea, vomiting, diarrhea) and severe pseudomembranous colitis.
Organ toxicity — acute interstitial nephritis (rarely).
Superinfections — oral candidiasis and vaginal candidiasis.

Why can phenoxymethylpenicillin be given orally while benzylpenicillin cannot?

Due to a difference in chemical structure. The presence of the phenoxymethyl group makes it resistant to gastric hydrochloric acid, whereas benzylpenicillin is completely destroyed in it.

Is the drug active against bacteria that produce penicillinase?

No. Like all natural penicillins, it is vulnerable and easily inactivated by bacterial enzymes—$eta$-lactamases.

Does the antimicrobial spectrum of phenoxymethylpenicillin differ from benzylpenicillin?

No, their spectrum of antimicrobial activity is completely identical (relatively narrow).

Go deeper

Mechanism of action of $\beta$-lactam antibiotics on the bacterial cell wall
Types and clinical significance of bacterial $\beta$-lactamases
Detailed spectrum of activity of benzylpenicillin (susceptible microorganisms)
Penicillin depot preparations (Bicillins) and their clinical uses
Semisynthetic penicillins: how pharmacology overcame the limitations of natural drugs